ECSP056238A - Tableta que comprende fluvastatina y carmelosa de calcio. - Google Patents

Tableta que comprende fluvastatina y carmelosa de calcio.

Info

Publication number
ECSP056238A
ECSP056238A EC2005006238A ECSP056238A ECSP056238A EC SP056238 A ECSP056238 A EC SP056238A EC 2005006238 A EC2005006238 A EC 2005006238A EC SP056238 A ECSP056238 A EC SP056238A EC SP056238 A ECSP056238 A EC SP056238A
Authority
EC
Ecuador
Prior art keywords
tablet
carmelosa
calcium
fluvastatin
includes fluvastatin
Prior art date
Application number
EC2005006238A
Other languages
English (en)
Inventor
Tomoyuki Uehara
Kenji Taguchi
Kenichi Kitaoka
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP056238A publication Critical patent/ECSP056238A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una tableta que contiene fluvastatina, en particular a una tableta que contiene fluvastatina la cual tiene una excelente propiedad de desintegración y una buena biodisponibilidad. La tableta que contiene fluvastatina se caracteriza porque comprende carmelosa-calcio como un agente de desintegración.
EC2005006238A 2003-06-25 2005-12-19 Tableta que comprende fluvastatina y carmelosa de calcio. ECSP056238A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003181349 2003-06-25

Publications (1)

Publication Number Publication Date
ECSP056238A true ECSP056238A (es) 2006-04-19

Family

ID=33549526

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005006238A ECSP056238A (es) 2003-06-25 2005-12-19 Tableta que comprende fluvastatina y carmelosa de calcio.

Country Status (21)

Country Link
US (1) US20090117181A1 (es)
EP (1) EP1641440B1 (es)
KR (1) KR20060030480A (es)
CN (1) CN1809342A (es)
AT (1) ATE471713T1 (es)
AU (1) AU2004251439B2 (es)
BR (1) BRPI0411855A (es)
CA (1) CA2529447A1 (es)
CO (1) CO5650224A2 (es)
DE (1) DE602004027808D1 (es)
EC (1) ECSP056238A (es)
IL (1) IL172531A0 (es)
IS (1) IS8249A (es)
MA (1) MA27889A1 (es)
MX (1) MXPA05013943A (es)
NO (1) NO20060261L (es)
NZ (1) NZ544119A (es)
RU (1) RU2361582C2 (es)
TN (1) TNSN05330A1 (es)
WO (1) WO2005000276A1 (es)
ZA (1) ZA200509930B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0708191A2 (pt) * 2006-02-24 2012-05-29 Teva Pharma " composições farmacêuticas de fluvastatina sódica "
WO2012049156A1 (en) * 2010-10-12 2012-04-19 Bayer Animal Health Gmbh Non-starch based soft chewables
US9399064B2 (en) 2011-04-12 2016-07-26 Sawai Pharmaceutical Co., Ltd. Pitavastatin-containing preparation and method for producing same
CN102309452B (zh) * 2011-09-14 2013-01-23 海南美大制药有限公司 氟伐他汀钠脂质体固体制剂
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN104069502B (zh) * 2013-03-29 2018-02-16 北京罗诺强施医药技术研发中心有限公司 复合骨架材料及其药物组合物
CN104095850B (zh) * 2013-04-03 2019-04-05 深圳信立泰药业股份有限公司 一种稳定的匹伐他汀钙药物组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
HU217629B (hu) * 1991-12-12 2000-03-28 Novartis Ag. Eljárás fluvasztatint tartalmazó stabilizált gyógyszerkészítmények előállítására
GB9703388D0 (en) * 1997-02-18 1997-04-09 Sandoz Yakuhin K K Tokyo Sykk Organic compounds
AR035016A1 (es) * 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
EP1254667A4 (en) * 2000-02-10 2003-03-12 Takeda Chemical Industries Ltd MEDICINE COMPRISING A COMBINATION
US20020025952A1 (en) * 2000-07-06 2002-02-28 American Home Products Corporation Combinations of statins, estrogens and estrogenic agents
US7510728B2 (en) * 2000-10-06 2009-03-31 Takeda Pharmaceutical Company Limited Solid preparations

Also Published As

Publication number Publication date
KR20060030480A (ko) 2006-04-10
ZA200509930B (en) 2007-01-31
ATE471713T1 (de) 2010-07-15
RU2006101889A (ru) 2007-08-10
CA2529447A1 (en) 2005-01-06
DE602004027808D1 (de) 2010-08-05
AU2004251439B2 (en) 2008-09-11
CO5650224A2 (es) 2006-06-30
US20090117181A1 (en) 2009-05-07
MXPA05013943A (es) 2006-02-24
EP1641440A1 (en) 2006-04-05
AU2004251439A1 (en) 2005-01-06
BRPI0411855A (pt) 2006-08-29
EP1641440B1 (en) 2010-06-23
MA27889A1 (fr) 2006-05-02
NZ544119A (en) 2008-04-30
NO20060261L (no) 2006-01-18
IS8249A (is) 2006-01-20
IL172531A0 (en) 2006-04-10
WO2005000276A1 (en) 2005-01-06
RU2361582C2 (ru) 2009-07-20
TNSN05330A1 (en) 2007-07-10
CN1809342A (zh) 2006-07-26

Similar Documents

Publication Publication Date Title
CR7076S (es) Recipiente
HN2003000227A (es) Inhibidores de quinasas
BRPI0411897A (pt) pirroldihidroisoquinolinas como inibidores de pde10
CA113787S (en) Lever
HN2005035436A (es) Caja de empaque
CO5650224A2 (es) Tableta que comprende fluvastatina y carmelosa-calcio
BRPI0417205A (pt) composições farmacêuticas
HN2005035435A (es) Caja de empaque
UY30023A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor calcico y las composiciones farmaceuticas que la contienen
HN2005035437A (es) Caja de empaque
HN2005035440A (es) Caja de empaque
CA113788S (en) Lever
DE50304218D1 (de) Sanitärkabine
NL1025055A1 (nl) Verbeterd lampontwerp.
TW200500081A (en) Novel rotaviruses and use thereof
ES1051309Y (es) Desmenuzador de especias.
AU306880S (en) Flask (bottle)
ES1053602Y (es) Cerradura de doble bombillo.
UY3566Q (es) Diseno de envase
ES1053557Y (es) Luminaria vertical empotrable.
ES1052367Y (es) Martillo de emergencia de facil localizacion.
AU308285S (en) Navigation system
AU308000S (en) Navigation system
ES1050861Y (es) Pantalla de lampara.
AU303058S (en) Hat